Education, press, and materials on the AMR problem we work on.
We publish short-form education about antimicrobial resistance and share downloadable materials for hospitals, researchers, and partners.
AMR Awareness Weekly
A short weekly series on antimicrobial resistance — the science, the numbers, and what precision diagnostics can change. Coming soon on our LinkedIn.
BactoAI one-pager
A concise overview of the platform, our validation approach, and current pilot opportunities. Email us for early access.
Press & mentions
KUTV Kenya's AMR interview, BIK Ventures Hub coverage, our press kit, brand assets, and a direct media contact — all on the press page.
AMR primer for founders & clinicians
A curated set of WHO, CDC, and peer-reviewed references we return to when explaining why AMR is a slow-moving global crisis. In preparation.
Ideas from the AMR frontier.
Research notes, clinical perspectives, and public-health analysis from the BactoAI team and partners.
Why genomic AMR prediction is the diagnostic upgrade hospitals actually need
Culture-based testing was designed for a world with fewer resistant strains. Here's what changes when the genome, not the culture plate, becomes the primary signal.
How we validated our Meropenem model to 0.952 ROC-AUC
A behind-the-scenes look at the training set, holdout strategy, and confidence-calibration work that produced BactoAI's flagship prediction model.
AMR in LMIC hospitals: what the surveillance data isn't telling you
A short field note from our pilot deployments across East African hospitals — and why local genomic surveillance changes the risk picture entirely.